Your browser doesn't support javascript.
loading
STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer.
Ghaffari, Abdi; Peterson, Nichole; Khalaj, Kasra; Vitkin, Natasha; Robinson, Andrew; Francis, Julie-Ann; Koti, Madhuri.
Afiliação
  • Ghaffari A; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.
  • Peterson N; Department of Obstetrics and Gynecology, Kingston Health Sciences Center, Queen's University, Kingston, ON, Canada.
  • Khalaj K; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.
  • Vitkin N; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.
  • Robinson A; Department of Oncology, Kingston Health Sciences Center, Queen's University, Kingston, ON, Canada.
  • Francis JA; Department of Obstetrics and Gynecology, Kingston Health Sciences Center, Queen's University, Kingston, ON, Canada.
  • Koti M; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada. kotim@queensu.ca.
Br J Cancer ; 119(4): 440-449, 2018 08.
Article em En | MEDLINE | ID: mdl-30046165

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Carboplatina / Cistadenocarcinoma Seroso / Proteínas de Membrana / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Carboplatina / Cistadenocarcinoma Seroso / Proteínas de Membrana / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2018 Tipo de documento: Article